IM Cannabis (IMCC) Interest Expenses (2020 - 2026)
IM Cannabis' (IMCC) quarterly Interest Expenses came in at $901298.2 in Q1 2026, up 156.6% year-on-year from $351245.9 in Q1 2025, and down 70.2% quarter-over-quarter from $3.0 million in Q4 2025.
IM Cannabis (IMCC) Interest Expenses (2020 - 2026) Analysis & Trends
IM Cannabis' Interest Expenses history runs 7 years deep, the most recent figure standing at $901298.2 for Q1 2026.
- On a quarterly basis, Interest Expenses rose 156.6% year-over-year to $901298.2 in Q1 2026; TTM through Mar 2026 was $2.2 million, a 192.8% increase from a year earlier, with the FY2025 full-year figure at $2.5 million, down 27.94% from the prior year.
- Interest Expenses fell to $901298.2 in Q1 2026 per IMCC's latest filing, from $3.0 million in the prior quarter.
- Across five years, Interest Expenses topped out at $5.2 million in Q3 2022 and bottomed at -$5.3 million in Q4 2022.
- The 5-year median for Interest Expenses is -$5141.7 (2023), against an average of $140578.2.
- Across the five-year window, Interest Expenses jumped 1719.51% in 2022 and slumped 29067.2% in 2024, its largest moves.
- Year by year, Interest Expenses stood at -$5.3 million in 2022, then jumped by 99.9% to -$5141.7 in 2023, then slumped by 29067.2% to -$1.5 million in 2024, then surged by 301.68% to $3.0 million in 2025, then tumbled by 70.2% to $901298.2 in 2026.
- Per Business Quant, the three latest IMCC Interest Expenses figures stand at $901298.2 (Q1 2026), $3.0 million (Q4 2025), and -$495565.1 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | 62.00 Mn |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | 944.51 Mn |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | 1.77 Bn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | 1.21 Bn |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | 590.20 Mn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | 57.00 Mn |
| 10 | IM Cannabis | 554,496.00 | -177,626.51 | 1.03 Mn | 901,298.24 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 901,298.24 |
| Mar 31, 2026 | 901,298.24 |
| Dec 31, 2025 | 3.02 Mn |
| Dec 31, 2025 | 3.02 Mn |
| Sep 30, 2025 | -495,565.07 |
| Sep 30, 2025 | -495,565.07 |
| Jun 30, 2025 | -1.27 Mn |
| Jun 30, 2025 | -1.27 Mn |
| Mar 31, 2025 | 351,245.90 |
| Mar 31, 2025 | 351,245.90 |
| Dec 31, 2024 | -1.50 Mn |
| Dec 31, 2024 | -1.50 Mn |
| Sep 30, 2024 | -114,356.33 |
| Sep 30, 2024 | -114,356.33 |
| Jun 30, 2024 | -1.07 Mn |
| Jun 30, 2024 | -1.07 Mn |
| Mar 31, 2024 | 297,587.40 |
| Mar 31, 2024 | 297,587.40 |
| Dec 31, 2023 | -5,141.75 |
| Dec 31, 2023 | -5,141.75 |